Evidence map›Paper›PMID 40565144›Full record

ArticleInternational journal of molecular sciences2025

Uropathogenic

Beata Krawczyk, Paweł Wityk, Magdalena Burzyńska, Tomasz Majchrzak, Michał Jan Markuszewski

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Potato (Molecules (Basel, Switzerland) · 2026
    Article
  3. Review
  4. Review
  5. Whole-genome characterisation of Escherichia coli isolates from older women with urinary tract infection and asymptomatic bacteriuria.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  6. The Role ofInternational journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Beata KrawczykDepartment of Biotechnology and Microbiology, Faculty of Chemistry, Gdańsk University of Technology, 80-233 Gdańsk, Poland.ORCID 0000-0001-5528-8898
Paweł WitykDepartment of Biopharmaceutics and Pharmacodynamics, Medical University of Gdańsk, 80-210 Gdańsk, Poland.
Magdalena BurzyńskaDepartment of Biotechnology and Microbiology, Faculty of Chemistry, Gdańsk University of Technology, 80-233 Gdańsk, Poland.
Tomasz MajchrzakDepartment of Analytical Chemistry, Faculty of Chemistry, Gdańsk University of Technology, 80-233 Gdańsk, Poland.ORCID 0000-0002-1738-1992
Michał Jan MarkuszewskiDepartment of Biopharmaceutics and Pharmacodynamics, Medical University of Gdańsk, 80-210 Gdańsk, Poland.ORCID 0000-0003-1166-4817

Funding

Ministry of Education and Science NdS-II/SP/0438/2024/01National Science Center 2018/29/B/NZ7/02489
6 · The paper itself

Abstract

In the absence of fully effective therapies and preventive strategies against the development of urosepsis, a deeper understanding of the virulence mechanisms of Uropathogenic

Indexed as

Escherichia coli InfectionsSepsisUrinary Tract InfectionsUropathogenic Escherichia coliEscherichia coli ProteinsFemaleHumansMaleMetabolomicsMiddle AgedProteomicsVirulence FactorsEscherichia coli ProteinsVirulence FactorsEscherichia colimarkersOMICS technologypathogenesissepsisUPECvirulence

Identifiers

PMID40565144
PMCPMC12193174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.